What are the outcomes of lupus disease activity in smokers compared to non-smokers while on hydroxychloroquine treatment?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18141629
Cited by: 0

Abstract

Smoking negatively affects hydroxychloroquine's effectiveness in SLE patients, leading to increased disease activity, particularly in cutaneous symptomatology.

Fields of Study & Subjects

Drug-Induced Ocular Toxicity Systemic Lupus Erythematosus Research High Altitude and Hypoxia

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
3 January 2026